BAIYAO (white drug) (sic) of Yunnan has not been responded " Divulge a secret on the door " If true must bear legal responsibility

BAIYAO (white drug) (sic) of Yunnan has not been responded " Divulge a secret on the door " If true must bear legal responsibility
Yesterday ( December 15) " daily economic news " report one <>Have caused readers' extensive concern. BAIYAO (white drug) (sic) ( 000538, SZ) of Yunnan "privacy fill a prescription " Keep at home secret, but open on the international market. If BAIYAO (white drug) (sic) of Yunnan divulges a secret, whether offend against the relevant laws and regulations of our country? In addition, two pieces of national first class traditional Chinese medicine of BAIYAO (white drug) (sic) of Yunnan protect the variety as Yunnan BAIYAO (white drug) (sic) capsule and BAIYAO (white drug) (sic) pulvis of Yunnan, but there are varied products to filling a prescription in BAIYAO (white drug) (sic) of Yunnan " Keep secret " ,Does this have suspicion of playing the edge ball? Yesterday, " daily economic news " reporter brought various queries, it is surnamed the staff member to telegraph a grandson of general manager office of BAIYAO (white drug) (sic) in Yunnan, she says that unable to make on this responding at present. Subsequently, the reporter telegraphs Yunnan Vice President Wang Jin of BAIYAO (white drug) (sic) again, she says this is unified and responded by general manager office, oneself inconvenience is divulged. Big rich lawyer's office executive director Li WeiMin in Beijing thinks: "If BAIYAO (white drug) (sic) of Yunnan divulges a secret, the company violates the secret relevant laws and regulations, need to bear legal liability. " If divulging a secret must bear legal liability to the above-mentioned incident, Li WeiMin expresses when being interviewed by " daily economic news " reporter, "once a certain country discloses filling a prescription in the whole world, that has been all disclosed in the other countries, this means plaster that disclosed BAIYAO (white drug) (sic) of Yunnan in a disguised form. " Li WeiMin thinks, sets up the double consideration with interests of the State and enterprise's interests of secret prescription, classified as the national secret prescription, is obligated to observe as enterprises. Look from country and national angle, this kind of way to disclose the prescription indirectly, have damaged country and national interests. It is reported, involve the laws and regulations of secret protection including " the People's Republic of China guard the national secret law ", " secret regulation of science and technology ", " Chinese and Western medicines, secret specification of science and technology of medical equipment ", " the secret of Chinese home of the hygiene job and regulation of the concrete range of security ",etc.. Li WeiMin says: "If BAIYAO (white drug) (sic) of Yunnan fills a prescription and divulges a secret, the company violates the secret relevant laws and regulations, need to bear legal liability. " But bear what legal liability remain, study also, disclose the prescription method and the difference stores in publicly directly indirectly specifically. In the investigation about " how of Homeway.com to think about the secret prescription of BAIYAO (white drug) (sic) of Yunnan to disclose in U.S.A. ", up to will it be 30 past 19 yesterday, oppose Yunnan BAIYAO (white drug) (sic) fill a prescription public netizen account for 76.82% in U.S.A., the ones that supported only had 8.5%. " keep secret " Become the shield in external world's view, the varied products should not be listed in secret range, but unified Israel of BAIYAO (white drug) (sic) of Yunnan " The secret prescription " Reason refuse announcement fill a prescription composition. Li WeiMin gives an example with BAIYAO (white drug) (sic) toothpaste of Yunnan, the prescription compositions with BAIYAO (white drug) (sic) of Yunnan are keeping secret in this product, but can't say it is secret that the products of the whole toothpaste fill a prescription. "According to the regulation of the country, the company should disclose this part of compositions. " In the view of Li Wei the people, this kind of method of BAIYAO (white drug) (sic) of Yunnan has already encroached on consumers' right of being in know, suspected of being involved in swindling. This kind of " magnified " Prescriptions national and secret can last consumer eyeball,stimulate by consumer desire to buy; On the other hand become the company again " The shield " ,Required by consumers many times " Disclose the prescription composition " Case in,Yunnan the BAIYAO (white drug) (sic), Yes, reach a standard on the grounds of secret prescription smoothly. "I think fill a prescription, should write get on, the craft is kept secret until come on. Because doctors should look at and fill a prescription to write a prescription, if has not filled a prescription, the doctor writes a prescription to probably want to hesitate. " China throws advisor medical trade researcher Guo FanLi to say to " daily economic news " reporter. Under the disturbance stranded, kept inside information from outsiders in secret prescription of BAIYAO (white drug) (sic) of Yunnan of the internationalization of traditional Chinese medicine, what made people worried even more is, because various supervisory systems are in line with international standards to still need break-in, the way of the internationalization of traditional Chinese medicine seems still very long. Guo FanLi says to " daily economic news " reporter, unable to connect with world because of supervising too, it is very difficult for traditional Chinese medicine to enter the international market at present. It is reported, the supervision looks to medicines is more domestic and stricter abroad. The official website of BAIYAO (white drug) (sic) of Yunnan reveals, the sale of BAIYAO (white drug) (sic) of Yunnan has already spread all over a plurality of countries such as U.S.A., Canada at present. Guo FanLi says, it is by way of health product or meal additive that domestic medicines want to enter the international market. On March 31 next year, traditional Chinese medicine will " grow the life-and-death struggle " on European Union market Also fall definitely. It is reported, the experience that must have used medicine in European Union at home for 30 years while going on in the enterprises registered, experience of using medicine in European Union for 15 years. "European Union give the intersection of buffer and issue of 7 year such as traditional Chinese medicine, but China, enterprise offer, should prove at present. " Guo FanLi says, " the task of top priority is at present, traditional Chinese medicine enterprises need to do one's own norm, policy, entry well, adopt the scientific method to supervise to planting, gathering etc.. " (Source: Daily economic newspaper-man: Cicada of the Guo 's)

|